HEXD (hexosaminidase D) is a nucleocytoplasmic β-hexosaminidase enzyme that catalyzes the hydrolytic cleavage of N-acetylglucosamine (GlcNAc) and N-acetylgalactosamine (GalNAc) monosaccharides from cellular glycoconjugate substrates 1. The enzyme demonstrates a preference for galactosaminide over glucosaminide substrates 1. Mechanistically, HEXD operates as a retaining glycosidase utilizing a substrate-assisted catalytic mechanism, with critical catalytic residues including Asp148 (polarizing residue) and Glu149 (general acid/base) 1. The enzyme exhibits optimal activity at pH 6.5-7.0 and is inhibited by Gal-NAG-thiazoline (Ki = 420 nM) 1. HEXD possesses a conserved glutamate residue characteristic of human hexosaminidases, positioning it within the broader GH20 glycosyl hydrolase family involved in glycoconjugate metabolism 2. Despite its well-characterized enzymatic mechanism, the physiological role and disease relevance of HEXD remain elusive 1. Further investigation is needed to establish its specific cellular functions and potential clinical significance in glycoprotein and glycolipid degradation pathways.